BOOK
Meningiomas, An issue of Neurosurgery Clinics of North America, E-Book
Gabriel Zada | Randy L. Jensen
(2016)
Additional Information
Book Details
Abstract
This issue focuses on meningiomas and includes articles on Incidental Meningiomas: Management Strategies in the Modern Neuroimaging Era, Advanced Neuroimaging for Intracranial Meningiomas, Endoscopic Endonasal and Keyhole Surgery for the Management of Skull Base Meningiomas, Preoperative Embolization for Intracranial Meningiomas, Management of Spinal Meningiomas, Medical Management of Meningiomas: Current Status, Failed Treatments and Promising Horizons, and many more!
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Meningiomas\r | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| CONSULTING EDITORS | iii | ||
| EDITORS | iii | ||
| AUTHORS | iii | ||
| Contents | vii | ||
| Preface: Meningiomas: An Update on Diagnostic and Therapeutic Approaches\r | vii | ||
| Advanced Imaging of Intracranial Meningiomas\r | vii | ||
| Predicting Meningioma Consistency on Preoperative Neuroimaging Studies\r | vii | ||
| Strategic and Technical Considerations for the Endovascular Embolization of Intracranial Meningiomas\r | vii | ||
| Genomic and Epigenomic Landscape in Meningioma\r | viii | ||
| Secretory Meningiomas: Characteristic Features and Clinical Management of a Unique Subgroup\x0B | viii | ||
| Primary Intraosseous Meningioma\r | viii | ||
| Management of Spinal Meningiomas\r | viii | ||
| Endoscopic Endonasal and Keyhole Surgery for the Management of Skull Base Meningiomas\r | ix | ||
| The Contemporary Role of Stereotactic Radiosurgery in the Treatment of Meningiomas\r | ix | ||
| Incidental Meningiomas: Management in the Neuroimaging Era\r | ix | ||
| Management of Atypical and Anaplastic Meningiomas\r | ix | ||
| Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons\r | x | ||
| Index\r | x | ||
| NEUROSURGERY CLINICS OF NORTH AMERICA\r | xi | ||
| FORTHCOMING ISSUES | xi | ||
| July 2016 | xi | ||
| October 2016 | xi | ||
| January 2017 | xi | ||
| RECENT ISSUES | xi | ||
| January 2016 | xi | ||
| October 2015 | xi | ||
| July 2015 | xi | ||
| Preface: Meningiomas: An \rUpdate on Diagnostic and Therapeutic Approaches | xiii | ||
| Advanced Imaging of Intracranial Meningiomas | 137 | ||
| Key points | 137 | ||
| BACKGROUND | 137 | ||
| PERFUSION IMAGING | 138 | ||
| DIFFUSION IMAGING | 140 | ||
| SPECTROSCOPY | 141 | ||
| NUCLEAR MEDICINE | 142 | ||
| SUMMARY | 142 | ||
| REFERENCES | 142 | ||
| Predicting Meningioma Consistency on Preoperative Neuroimaging Studies | 145 | ||
| Key points | 145 | ||
| INTRODUCTION | 145 | ||
| REFERENCE STANDARDS OF MENINGIOMA CONSISTENCY | 146 | ||
| NEUROIMAGING STUDIES OF MENINGIOMA CONSISTENCY | 146 | ||
| Conventional MRI | 146 | ||
| Diffusion MRI | 147 | ||
| Magnetic Resonance Elastography | 151 | ||
| Magnetic Resonance Spectroscopy | 152 | ||
| Computed Tomography | 152 | ||
| Other Imaging Techniques | 152 | ||
| SUMMARY | 153 | ||
| REFERENCES | 153 | ||
| Strategic and Technical Considerations for the Endovascular Embolization of Intracranial Meningiomas | 155 | ||
| Key points | 155 | ||
| INTRODUCTION: NATURE OF THE PROBLEM | 155 | ||
| INDICATIONS AND CONTRAINDICATIONS | 156 | ||
| OPERATIVE TECHNIQUE AND PROCEDURE | 156 | ||
| Preoperative Planning | 156 | ||
| PROCEDURAL CONSIDERATIONS | 156 | ||
| Timing | 156 | ||
| Preparation and Patient Positioning | 157 | ||
| SURGICAL APPROACH AND SURGICAL PROCEDURE | 157 | ||
| Endovascular Technique | 157 | ||
| SELECTION OF AN EMBOLIC AGENT | 158 | ||
| Particles | 158 | ||
| Liquid Embolic Agents | 160 | ||
| Other Embolic Agents | 160 | ||
| DANGEROUS ANASTOMOSES | 160 | ||
| Orbital Region | 160 | ||
| Parasellar Region | 160 | ||
| Petroclival Region | 160 | ||
| Cervicomedullary Region | 162 | ||
| Cranial Nerve Blood Supply | 162 | ||
| COMPLICATIONS AND THEIR MANAGEMENT | 162 | ||
| POSTOPERATIVE CARE | 164 | ||
| OUTCOMES | 164 | ||
| SUMMARY | 164 | ||
| REFERENCES | 164 | ||
| Genomic and Epigenomic Landscape in Meningioma | 167 | ||
| Key points | 167 | ||
| INTRODUCTION | 167 | ||
| GENOMICS AND EPIGENOMICS IN MENINGIOMA | 168 | ||
| Genetic Alterations | 168 | ||
| Chromosomal Copy Number Alterations | 169 | ||
| Epigenetic Alterations | 169 | ||
| MOLECULAR TAXONOMY IN MENINGIOMA | 172 | ||
| Genetic Hallmarks of Meningioma Subtypes | 172 | ||
| Epigenetic Stratification of Meningiomas | 173 | ||
| MOLECULAR PREDICTORS OF CLINICAL OUTCOME | 173 | ||
| SUMMARY | 176 | ||
| ACKNOWLEDGEMENT | 176 | ||
| REFERENCES | 176 | ||
| Secretory Meningiomas | 181 | ||
| Key points | 181 | ||
| INTRODUCTION | 181 | ||
| CLINICAL PRESENTATION AND IMAGING | 181 | ||
| HISTOPATHOLOGY AND GENETICS | 182 | ||
| CLINICAL MANAGEMENT AND COMPLICATIONS | 184 | ||
| SUMMARY | 185 | ||
| REFERENCES | 185 | ||
| Primary Intraosseous Meningioma | 189 | ||
| Key points | 189 | ||
| INCIDENCE | 189 | ||
| ETIOLOGY | 189 | ||
| CLINICAL PRESENTATION | 190 | ||
| RADIOGRAPHIC APPEARANCE | 190 | ||
| DIFFERENTIAL DIAGNOSIS | 191 | ||
| HISTOPATHOLOGY | 191 | ||
| NOMENCLATURE AND CLASSIFICATION | 191 | ||
| TREATMENT | 192 | ||
| SUMMARY | 192 | ||
| REFERENCES | 193 | ||
| Management of Spinal Meningiomas | 195 | ||
| Key points | 195 | ||
| INTRODUCTION | 195 | ||
| Epidemiology | 195 | ||
| Surgical Management | 196 | ||
| Genetic and Molecular Markers | 197 | ||
| Tumor Locations | 197 | ||
| PATIENT EVALUATION OVERVIEW | 198 | ||
| SURGICAL APPROACH | 199 | ||
| Neuromonitoring | 201 | ||
| SURGICAL COMPLICATIONS | 201 | ||
| FUNCTIONAL AND NEUROLOGIC OUTCOME | 202 | ||
| SPINAL MENINGIOMA RECURRENCE | 202 | ||
| PHARMACOLOGIC TREATMENT OPTIONS | 202 | ||
| ADJUVANT RADIOTHERAPY AND RADIOSURGERY | 203 | ||
| SUMMARY/DISCUSSION | 203 | ||
| SUPPLEMENTARY DATA | 203 | ||
| REFERENCES | 203 | ||
| Endoscopic Endonasal and Keyhole Surgery for the Management of Skull Base Meningiomas | 207 | ||
| Key points | 207 | ||
| INTRODUCTION | 207 | ||
| THE SUPRAORBITAL KEYHOLE APPROACH | 207 | ||
| The Supraorbital Keyhole Approach Technique | 209 | ||
| THE ENDOSCOPIC ENDONASAL APPROACH | 210 | ||
| The Endoscopic Endonasal Approach Technique | 210 | ||
| DISCUSSION | 212 | ||
| SUMMARY | 213 | ||
| REFERENCES | 213 | ||
| The Contemporary Role of Stereotactic Radiosurgery in the Treatment of Meningiomas | 215 | ||
| Key points | 215 | ||
| INTRODUCTION | 215 | ||
| Meningioma Classification and Epidemiology | 215 | ||
| Brief Overview of Resection | 216 | ||
| The Evolution of Radiosurgery | 216 | ||
| THE RADIOBIOLOGY OF RADIOSURGERY | 218 | ||
| RADIOSURGICAL RESULTS FOR WORLD HEALTH ORGANIZATION CLASS I BENIGN MENINGIOMAS | 219 | ||
| The Effect of Dose and Tumor Volume on Prognosis | 219 | ||
| Tumor Control Rates Based on the Duration of Follow-up | 219 | ||
| Stereotactic Radiosurgery as a Primary Treatment Modality | 220 | ||
| Long-term Radiosurgical Outcomes | 220 | ||
| Skull Base Meningiomas | 221 | ||
| Convexity Meningiomas | 222 | ||
| RADIOSURGERY FOR ATYPICAL AND MALIGNANT MENINGIOMAS | 222 | ||
| RADIOSENSITIVITY OF CRANIAL NERVES | 223 | ||
| HYPOFRACTIONATED STEREOTACTIC RADIOSURGERY | 223 | ||
| STEREOTACTIC RADIOSURGERY–INDUCED COMPLICATIONS | 224 | ||
| SUMMERY: THE ROLE FOR STEREOTACTIC RADIOSURGERY IN THE MANAGEMENT OF MENINGIOMAS | 224 | ||
| REFERENCES | 225 | ||
| Incidental Meningiomas | 229 | ||
| Key points | 229 | ||
| INTRODUCTION | 229 | ||
| DIAGNOSTIC NEUROIMAGING TECHNIQUES | 230 | ||
| MRI | 230 | ||
| Computed Tomography | 230 | ||
| Single-Photon Emission Computed Tomography | 232 | ||
| MANAGEMENT | 232 | ||
| Surgical Resection | 232 | ||
| Radiation | 233 | ||
| Observation | 234 | ||
| SUMMARY | 235 | ||
| REFERENCES | 235 | ||
| Management of Atypical and Anaplastic Meningiomas | 239 | ||
| Key points | 239 | ||
| INTRODUCTION | 239 | ||
| PATIENT EVALUATION OVERVIEW | 240 | ||
| SURGICAL TREATMENT OPTIONS | 242 | ||
| BRACHYTHERAPY | 242 | ||
| RADIOTHERAPY TREATMENT OPTIONS | 242 | ||
| PHARMACOLOGIC TREATMENT OPTIONS | 243 | ||
| TREATMENT RESISTANCE OR COMPLICATIONS | 243 | ||
| EXPERIMENTAL THERAPIES | 244 | ||
| EVALUATION OF OUTCOME AND LONG-TERM RECOMMENDATIONS | 245 | ||
| SUMMARY AND DISCUSSION | 245 | ||
| REFERENCES | 245 | ||
| Medical Management of Meningiomas | 249 | ||
| Key points | 249 | ||
| INTRODUCTION | 249 | ||
| MUTATIONS IN MENINGIOMA | 251 | ||
| ANGIOGENIC PATHWAY INHIBITORS | 254 | ||
| TYROSINE KINASE RECEPTOR INHIBITORS | 255 | ||
| HYDROXYUREA | 255 | ||
| HORMONE RECEPTOR TARGETED AGENTS | 255 | ||
| CHEMOTHERAPEUTIC AGENTS | 256 | ||
| SOMATOSTATIN ANALOGUES | 256 | ||
| IMMUNOMODULATION | 256 | ||
| EMERGING APPROACHES | 256 | ||
| REFERENCES | 257 | ||
| Index | 261 |